The Valley Desk

NCT03600883 · Interventional trial

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

Overall registry status Completed

Phase 1 · Phase 2

Conditions KRAS p.G12C Mutant Advanced Solid Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov